نتایج جستجو برای: hypercvad

تعداد نتایج: 72  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2014
J S Abramson T Feldman A R Kroll-Desrosiers L S Muffly E Winer C R Flowers F Lansigan C Nabhan L J Nastoupil R Nath A Goy J J Castillo D Jagadeesh B Woda S T Rosen S M Smith A M Evens

BACKGROUND Optimal frontline therapy for peripheral T-cell lymphoma (PTCL) in the modern era remains unclear. PATIENTS AND METHODS We examined patient characteristics, treatment, and outcomes among 341 newly diagnosed PTCL patients from 2000 to 2011. Outcome was compared with a matched cohort of diffuse large B-cell lymphoma (DLBCL) patients, and prognostic factors were assessed using univari...

2015
Masami Fujii Takayuki Ohguri Katsuya Yahara Hajime Imada Kyosuke Tomura Mai Sakagami Gunji Nagatani Hideaki Suzuki Yukunori Korogi

The purpose of this study was to investigate whether the overall treatment time and completion rates of chemotherapy were predictive factors for the survival rates in patients with squamous cell carcinoma of the head and neck (SCCHN) who were treated with concurrent chemoradiotherapy (CCRT) using hyperfractionated radiotherapy (RT) and daily carboplatin. The number of intermission days of RT we...

Journal: :Sarcoma 2001
R. Beverly Raney Harold M. Maurer James R. Anderson Richard J. Andrassy Sarah S. Donaldson Stephen J. Qualman Moody D. Wharam Eugene S. Wiener William M. Crist

Purpose. To enumerate lessons from studying 4292 patients with rhabdomyosarcoma (RMS) in the Intergroup Rhabdomyosarcoma Study Group (IRSG, 1972-1997).Patients. Untreated patients < 21 years of age at diagnosis received systemic chemotherapy, with or without irradiation (XRT) and/or surgical removal of the tumor.Methods. Pathologic materials and treatment were reviewed to ascertain compliance a...

Journal: :Journal of clinical and experimental hematopathology : JCEH 2011
Tetsumi Yoshida Akira Sakai Jun Imagawa Masaaki Noda Shinichi Takada Tadashi Yoshino Akiro Kimura

In August 2010, a 51-year-old man was transferred to our Hematology & Oncology Department from another hospital with a 1-month history of unknown fever, anasarca, and lymphadenopathy of bilateral neck, bilateral axilla, and bilateral inguen. Chest X-ray showed bilateral pleural effusion and swellings in the lymph nodes of the neck, axilla, mediastinum, paraaorta, and inguen ; furthermore, ascit...

Journal: :Hematology. American Society of Hematology. Education Program 2004
Richard I Fisher Thomas P Miller Owen A O'Connor

The aggressive non-Hodgkin's lymphomas can be cured in more than half of the cases. However, there has been great variation in the results reported from individual clinical Phase II trials. This variation in result can be attributed to unrecognized heterogeneity in this group of diseases. Recent clinical and molecular studies have enabled us to define more homogenous population in which new the...

2017
R Eslick L Dunlop M Lin D Hsu S Ling

18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scans are typically positive in patients with T cell non-Hodgkin lymphoma (T-NHL) and can assist in the diagnosis and staging of this uncommon malignancy. Previous studies have suggested that FDG-PET is a useful tool in initial staging of T-NHL; however, there is relatively little evidence for the role of the post-treatment FDGPET in...

2015
Y Collette T Prébet A Goubard J Adélaïde R Castellano N Carbuccia S Garnier A Guille C Arnoulet A Charbonier M J Mozziconacci D Birnbaum M Chaffanet N Vey

Tyrosine kinase inhibitor (TKI)-based targeted therapy has significantly modified the outcome for patients with chronic myeloid leukemia (CML) in chronic phase. However, resistance remains a major concern in blastic phase of CML and in Philadelphia chromosome positive B-cell acute lymphoblastic leukemia (Ph+ B-ALL). Secondand third-generation TKIs have been developed to overcome resistance to f...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید